Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccination

被引：4
|
作者：
Matsubara, Akihiro [1 ]
Sakurai, Mai [2 ]
Morita, Akimichi [2 ]
机构：
[1] Chita Kosei Hosp, Dept Dermatol, Mihama, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan
来源：
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY | 2021年 / 4卷 / 06期
关键词：
D O I：
10.1002/cia2.12199
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
We reported a patient with neutrophilic urticaria following COVID-19 vaccination who required high-dose steroid treatment.
引用
收藏
页码：187 / 188
页数：2
相关论文
共 50 条
  • [21] Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
    Yohhei Hamada
    Journal of Pharmaceutical Policy and Practice, 14
  • [22] Guillain-Barre syndrome following Pfizer-BioNTech (BNT162b2) vaccination: a case report
    Chaudhary, Aashutosh
    Khadka, Shrekshya
    Dulal, Aliza
    Adhikari, Rojeena
    Bhardwaj, Sushant
    Pandey, Abhishek
    Chaudhary, Ashlesha
    Bhusal, Suzit
    Acharya, Smriti
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (11): : 6693 - 6695
  • [23] Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech)
    Akiyama, Yutaro
    Inagaki, Takeshi
    Morioka, Shinichiro
    Kusano, Eiji
    Ohmagari, Norio
    INTERNAL MEDICINE, 2023, 62 (13) : 2013 - 2017
  • [24] A case of extensive alopecia areata following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine with favorable outcome
    Matsuda, Yoshihiro
    Kawakami, Yoshio
    Kawamoto, Masaya
    Hirai, Yoji
    Morizane, Shin
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 115 - 116
  • [25] Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital
    Palomo-Palomo, Cristina
    Guerra-Estevez, Dulce
    Parrado-Gonzalez, Alberto
    Estaire-Gutierrez, Julia
    Reyes-Malia, Miguel
    Mercedes Romero-Alonso, M.
    FARMACIA HOSPITALARIA, 2022, 46 (03) : 152 - 156
  • [26] Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review
    Cvetkovic, Mirjana
    Pantic, Nikola
    Virijevic, Marijana
    Pravdic, Zlatko
    Sabljic, Nikica
    Mitrovic, Mirjana
    Suvajdzic-Vukovic, Nada
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (06): : 800 - 804
  • [27] Clinicopathological Characteristics of Inflammatory Myositis Induced by COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report
    Kim, Ji Hyoun
    Kim, Jun Hyoung
    Woo, Chang Gok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (11)
  • [28] Cerebellar and brainstem stroke possibly associated with booster dose of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine
    Thomas, Michael George
    Dermawan, Andrew
    Teh, Sue
    BMJ CASE REPORTS, 2023, 16 (05)
  • [29] A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine
    Malayala, Srikrishna, V
    Papudesi, Bhavani N.
    Sharma, Rishika
    Vusqa, Urwat T.
    Raza, Ambreen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [30] Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
    Haq, Hannah N.
    Khan, Hafiz
    Chaudhry, Haroon
    Nimmala, Swathi
    Demidovich, Joseph
    Papudesi, Bhavani Nagendra
    Potluri, Sai Deepika
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2022, 114 (06) : 601 - 612
12345